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Purpose. Long-term results of the patients with total LSCD, who had undergone keratolimbal allograft (KLAL) for limbal re-
construction followed by penetrating keratoplasty (PK). Methods. +e study analyzes surgical treatment of 43 eyes with severe
ocular surface disorders. All subjects underwent KLAL to achieve suitable conditions for consecutive PK. Due to failures of
primary treatment in 17 eyes (39%), the KLAL was repeated. PK was performed in all the patients at 9-12 months after KLAL. As a
retrospective study we analyzed data from the medical records including the preoperative and postoperative best corrected visual
acuity, corneal clarity, surgical outcomes and complications, postoperative intraocular pressure, graft rejection, and other
comorbidities and complications. Results. +e preoperative visual acuity ranged from light perception to 0.01. +e final im-
provement of visual acuity within a gain of one or more lines with the Snellen chart, including the results of successive surgical
treatments after PK, was achieved in 23 operated eyes (53%). Early graft rejection was observed in 4 eyes (9%). In 3 eyes, it was
manifested as endothelial rejection, and in 1 eye, as combined endothelial and epithelial rejection. PK failure requiring repetitive
PK was present in 14 eyes (32%). Phthisis bulbi developed in 6 eyes (14%). Glaucoma or ocular hypertension was reported in 25
eyes (58%). A majority were treated with up to 3 topical agents or referred for trabeculectomy in 3 cases, transscleral cyclo-
photocoagulation in 2 eyes, and EX-PRESS glaucoma shunt implantation in 3 cases. Conclusions. Successful KLAL carries a high
risk of subsequent PK failure. Visual function remains the second aim of treatment; the primary one is to stabilize the surface.
1. Introduction
Limbal stem cell deficiency (LSCD) is characterized by the
reduction or loss of the stem cells in the limbus. +ese stem
cells are vital for the repopulation of the corneal epithelium
and the barrier function of the limbus. +e corneal epithelial
cells undergo constant renewal and regeneration. Cells from
the surface are desquamated and replaced by proliferating
basal epithelial cells from the periphery. +e destruction or
loss of these cells results in epithelial breakdown and per-
sistent epithelial defects, corneal conjunctivalization, neo-
vascularization, corneal scarring and chronic inflammation,
thick fibrovascular pannus, ulceration, corneal melting, and
consecutive perforation [1, 2]. It also contributes to the loss
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of corneal clarity, which is essential for good vision. Other
problems are chronic or recurrent pain, redness, and
photophobia.
LSCD may be primary in neurotrophic or endocrine
keratopathy, aniridia, or erythrokeratoderma) or secondary
to external factors, such as chemical or thermal burns,
ionizing or ultraviolet radiation, Stevens-Johnson syndrome
(SJS), ocular cicatricial pemphigoid, contact lens wear,
microbial infections, tumors, or multiple ocular surgeries
[1, 3–5].
+e management of LSCD depends on whether the
condition is unilateral or bilateral and involves some or all of
the limbal stem cells [1, 6]. In cases of transient limbal injury,
conservative medical treatment may sometimes be sufficient.
However, larger or total limbal stem cell deficiency requires
surgical management. +e choice of treatment methods and
the prognosis for successful surgery depend onmany factors,
[3] such as concomitant lid pathology, dry eye, and un-
controlled systemic disorders. +e reconstruction of an
appropriate limbal microenvironment involves limiting and
controlling the inflammation, improving the tear film, and
promoting the differentiation of the corneal epithelial cells
with medical and surgical methods [1, 3, 6, 7].
From the first ocular surface transplantations performed
by +oft, that is, conjunctival transplantation in 1977 and
keratoepithelioplasty in 1984, several surgical techniques
have been developed to treat and to reconstruct severely
damaged ocular surface epithelia [6]. +ey include autolo-
gous and allogenic limbal transplantation, simple limbal
epithelial transplant (SLET), cultivated limbal epithelial
transplantation (CLET), cultivated oral mucosal epithelial
transplantation (COMET), amniotic membrane transplan-
tation, keratolimbal allograft (KLAL), keratoprosthesis, and
synthetic corneas. +e options include living-related con-
junctival limbal allografts (lr-CLAL), cadaveric KLAL,
combined lr-CLAL and KLAL, and ex vivo expanded limbal
allograft. For unilateral disease, conjunctival limbal auto-
graft may be the best option. For bilateral disease, allogeneic
tissues are needed as stem cell sources [3, 8–10].
+e restoration of the ocular surface and final visual
acuity improvement in patients with partial or total limbal
stem cell deficiency often requires multistage and repetitive
surgical treatments to regenerate the normal corneal epi-
thelium and to create stable conditions for the final optical
penetrating keratoplasty (PK). Reconstructive surgery in-
volving simultaneous limbal transplantation and PK has
poorer long-term outcomes. It carries a high risk of very
serious complications and frequently requires successive
intensive medical and surgical treatments [1, 11].
+e aim of this study was to report on a sample of
patients who underwent surgical treatment for severe cor-
neal and ocular surface disorders. +e surgical treatments,
anatomical and functional results, and treatment compli-
cations in this group of patients are discussed.
2. Material and Methods
+e study was a retrospective review of the surgical treat-
ment of 43 eyes with severe ocular surface disorders. +e
operations were performed between January 1, 2010, and
August 31, 2018, at the Ophthalmology Department of Saint
Barbara Hospital, Trauma Center, Sosnowiec, Poland. +e
analyzed data from the medical records included demo-
graphics, medical histories, the preoperative and postop-
erative best spectacle-corrected visual acuity (BSCVA)
measured in accordance with the Snellen visual acuity (VA)
chart, corneal clarity, surgical outcomes and complications,
postoperative intraocular pressure, graft rejection and other
comorbidities and complications, and the results of the
accessory examinations (microbial tests). Surgeries were
performed by two experienced surgeons (KK, DD). All of the
patients signed an informed consent form before under-
going any surgical procedures. Under Polish law, this ret-
rospective observational study did not require the approval
of a local bioethics committee.
+e patients with severe bilateral ocular surface pa-
thology with total LSCD usually required multistage surgical
treatment. +e clinically based total LSCD diagnosis was
based on medical histories, patient observations, and
treatment responses. +e clinical manifestations of total
LSCD were nonhealing persistent corneal epithelial defects,
which often led to ulcerations, corneal melting or perfo-
ration, corneal superficial and deep neovascularization, fi-
brovascular pannus, scarring, keratinization and
calcification of the cornea, severe limbal ischemia in four
quadrants, and persistent limbal inflammation.+e first step
in the treatment of all of the patients who had been diag-
nosed with total LSCD and who had undergone complete
ocular examination was 360° KLAL. +e main purpose was
the achievement of suitable conditions for consecutive op-
tical PK. +e indications for the procedure included
chemical burns, thermal burns, and corneal post-
inflammatory and severe posttraumatic scars of the ocular
surface.
In many cases, the reconstruction of the ocular surface
required prior conjunctival fornix restoration, sym-
blepharolysis, ankyloblepharolysis, and lid procedures.
+e KLAL involved the preparation of the donor tissue,
the 360° corneoscleral ring that remains after corneal
trephination for PK, from cadaveric eyes. Oversized donor
grafts with 2–3mm scleral rims were preserved in a cold
storage medium of Eusol-C solution (Alchimia, Srl, Ponte S.
Nicolo, Italy). During surgery, the posterior one-half to two-
thirds of the stromal and scleral tissues were removed by
lamellar dissection with a sharp rounded steel crescent blade.
+e free-hand technique was used. A 360° conjunctival
peritomy was performed by exposing the limbus. All of the
corneal pannus and corneal irregularities were smoothed
and removed with a rounded blade. Hemostasis was ob-
tained by the topical application of 10% phenylephrine. +e
keratolimbal donor allograft was positioned and sutured
with 7-0 vicryl sutures to the recipient scleral bed. +e
corneal part of the allograft usually fitted closely to the
recipient cornea. Each recipient’s primary pushed-back
conjunctiva was sutured tightly with 10-0 vicryl 2mm
outside the limbus. +e patients were hospitalized for 1–2
days after KLAL. +ey were followed up 2 weeks after
hospitalization and monthly for 6 months.
2 Journal of Ophthalmology
In the patients in whom a stable ocular surface was ob-
tained, optical PK was subsequently performed. Criteria for
surgery continuation were as follows: no epithelial defects
prior to PK, no conjunctival ingrowth on corneal central area,
and no superficial neovascularization. For the PK, a Hanna
vacuum trephine system (Moria Inc., Antony, France) was
used. +e graft diameter was 7.5–8.5mm with an oversize of
0.5–0.75mm.+e donor-recipient junctionwas sewnwith 10-
0 nylon interrupted sutures. All of the patients were hospi-
talized for the first 2–5 days after PK. +ey were followed up
every 2 weeks for 2 months, monthly for a minimum of 6
months and at various intervals thereafter.
Surgery was followed by the intensive management of
epithelialization, local and systemic immunosuppression and
control of inflammation, and the management of coexisting
glaucoma and other comorbidities and complications.
All of the surgical procedures were performed under
general anesthesia. +e donor corneas originated from the
authors’ own or cooperative tissue banks.
XLSTAT-Biomed software (Addinsoft SARL, France)
was used for statistical analysis, including the calculation of
the means and standard deviations. +e outcome variables
were not assumed to have a normal distribution. +erefore,
one-way analysis of variance was used to compare the
baseline characteristics and postoperative outcomes re-
garding the causes of corneal disorders in the subgroups. A
value of <0.05 was considered statistically significant.
3. Results
+irty-five study subjects suffered from unilateral disease,
while bilateral LSCD was present in five patients. In a study
period 43 eyes of 40 patients with severe ocular surface
disorders leading to LSCD received KLAL and consecutive
PK at 9–12 months after the KLAL. +is patient group
consisted of 4 females, 4 eyes with themean age at the time of
KLAL being 52.25± 14.72 (range 37–71 years), and 36 males,
39 eyes with the mean age at the time of KLAL being
42.65± 12.29 (range 26–73 years). In 3 patients with LSCD
after chemical burns in both eyes, KLAL was performed.
+e primary causes of total LSCD that resulted from
severe corneal disorders and required KLAL are presented in
Table 1.
To create suitable conditions for PK in 17 eyes (39%), the
KLAL was repeated. +e anatomical and functional success
of this treatment was defined as the absence of persistent
epithelial defects and corneal conjunctivalization and neo-
vascularization on the corneal edge of the graft. Table 2
presents the characteristics of primary KLAL failure.
More than two KLAL procedures were not necessary in
these subjects.
Because of the complex nature of the underlying pa-
thologies, additional one-time or multiple surgical proce-
dures were performed subsequently. To achieve final useful
visual acuity and to manage the failure of the primary
surgical interventions, the eyes treated for LSCD initially
with KLAL and PK required successive surgical treatments.
+e preoperative BSCVA on Snellen charts ranged from
light perception to 0.01. +e final improvement of visual
acuity within a gain of one or more lines with the Snellen
test, including the results of successive surgical treatments
after PK, was achieved in 23 operated eyes (53%). Because of
the coexisting ocular diseases, such as glaucoma or retinal
disorders, the final visual outcome of the treatment was
limited. Table 3 presents the successive procedures that were
performed to improve visual acuity and final BSCVA.
Despite repeated surgical treatments and intensive anti-
inflammatory and immunosuppressive treatments, phthisis
bulbi developed in 6 eyes (14%).
In 2 eyes, successive PK after KLAL was not necessary
because of the remission of corneal neovascularization and
the return of satisfactory corneal transparency and visual
acuity. +e phacoemulsification with PCIOL implantation
was sufficient for improving final visual acuity. +ose pa-
tients were not included in this review.
+e post-KLAL medical treatment included a topical
steroid (dexamethasone 7 times per day), broad-spectrum
antibiotics (fluoroquinolones [moxifloxacin or levofloxacin]),
aminoglycosides (gentamycin), and systemic immunosup-
pression, including steroids (methylprednisolone 4–16mg
BID, and tapered), cyclosporine A (100mg, QD), azathioprine
(50mg BID), and mycophenolate mofetil (250–500mg BID).
Persistent intensive lubrication was very important for cre-
ating good conditions for epithelialization and maintaining
the success of the surgical and medical treatments. Topical
antimicrobial therapy was routinely applied for 21 days and
extended if needed. +e steroid doses were tapered (1 less
drop each month) to a maintenance treatment of 5 times per
day. +e modifications were applied on the basis of the
progress of the disease. Systemic long-term immunosup-
pression was continued with one of medications or in
combination of cyclosporine A (100mg, QD), azathioprine
(50mg BID), and mycophenolate mofetil (250–500mg BID).
PK was performed in all the patients at 9–12 months
after KLAL. In 7 eyes (16%), PK and cataract surgery with
PCIOL implantation were performed.
Because of the high risk of rejection with PK after KLAL,
topical and systemic steroid medications were continuously
administered postoperatively. Intensive immunosuppres-
sion and anti-inflammatory and antibiotic therapies were
also administered. In addition, the patients were treated with
cycloplegic and antiglaucomatous medications, if necessary.
All of the patients were followed up every 2 weeks for a
period of 2 months, monthly for a minimum of 6 months
and at varying intervals thereafter. +e mean observation
time was 24 months (1–60 months).
+ere were many complications from the two-step
surgical transplantation treatment. +e most common was
persistent epithelial defect, observed in 27 eyes (63%),
resulting from the impaired tear production and decreased
corneal sensitivity that was observed in all groups of patients
requiring surgical treatment. +e treatment of the erosions
consisted of intensive lubrication, the application of solution
of 20% autologous serum combined with an antibiotic agent
and dexamethasone. In 5 eyes, an amniotic membrane was
also applied for 2 weeks to support reepithelialization.
Early graft rejection was observed in 4 eyes (9%). In 3
eyes, it was manifested as endothelial rejection, and in 1 eye,
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as combined endothelial and epithelial rejection. All 4 cases
were successfully treated with intensive topical and systemic
anti-inflammatory and immunosuppressive medications.
PK failure requiring repetitive PK was present in 14 eyes
(32%). Mean to time to graft failure was 8.2± 5.8 months.
Nonmelting graft failure (23%) was attributed to stromal
vascularization with partial ocular surface conjunctivaliza-
tion (2 eyes), graft rejection with persistent edema (7 eyes),
and scarification of the stroma (1 eye). Keratomalacia oc-
curred in 4 eyes (9%). Neovascularization in the graft-host
interface, as that in the midperiphery of the corneal graft,
was caused by direct contact with the corneal limbus and
immunological mechanisms in the transplanted tissues.
Graft melting (keratomalacia) was observed mainly in the
PK for postinflammatory viral reinfection. Intensive anti-
viral and anti-inflammatory medications were required.
Figure 1 presents ocular surface conditions in successful and
failed cases.
Preoperative glaucoma recognized was present in 14
eyes (32%). All patients were treated with at least 1
antiglaucoma agent (timolol or brimonidine or brinzo-
lamide or combination of them). Glaucoma or ocular
hypertension in postoperative period, despite 1 application
of PK peripheral iridectomy in 11 eyes (26%), was reported
in 25 eyes (58%). A majority were treated with 1 or 3
topical agents (timolol, brimonidine, and brinzolamide) or
referred for trabeculectomy in 3 cases, transscleral
cyclophotocoagulation in 2 eyes, and EX-PRESS glaucoma
shunt implantation in 3 cases. +e main reason for
glaucoma was coexisting preoperative disease, intensive
steroid therapy, and shallow anterior chambers in the eyes
after keratoplasty. Anatomical reasons urged us to surgical
intervention, especially in the eyes of an unsatisfactory
response to topical treatment.
4. Discussion
+e limbal stem cell population is responsible for corneal
epithelial renewal and repair, which are crucial for corneal
transparency and good vision [2, 12]. LSCD, both primary
and secondary, leads to epitheliopathy, persistent epithelial
defects, inflammation of the corneal surface with consecu-
tive conjunctivalization and neovascularization of the cor-
nea, symblepharon and ankyloblepharon formation,
shortening of the fornices, and goblet cell, mucin and
aqueous tear deficiency [13–15].
Liang et al. [16] demonstrated the prevalence and threat
of surface deficits and the augmentation of the long-term
success of KLAL for eyes with total LSCD through the
application of corrective measures. +e maintenance of the
reservoir of the corneal epithelial cells is necessary for limbal
transplantation. +e success of corneal transplants is
Table 3: Successive surgical treatments after penetrating keratoplasty and final best spectacle-corrected visual acuity.
Surgical technique Total (n� 35) N (%) Final BSCVA (range)
Re-PK 10 (28.6) HM – 0.2
Re-PK with cataract surgery and PCIOL implantation 3 (8.6) 0.1–0.3
Cataract surgery with PCIOL implantation 7 (20.0) 0.1–0.5
Secondary PCIOL implantation 2 (5.7) 0.02–0.3
Transscleral fixation of IOL 3 (8.6) 0.05–0.1
Glaucoma surgery 8 (22.6) LP – 0.01
Pars plana vitrectomy (PPV) 2 (5.7) HM – 0.1
CF: counting fingers; HM: hand movements.
Table 1: Causes of total limbal stem cell deficiency (% in brackets).
Cause of total LSCD Total (N� 43) N (100%) Female (n� 4) n (9.3%) Male (n� 39) n (90.7%)
Chemical burn 25 (58.1) 2 (4.7) 23 (53.5)
+ermal burn 8 (18.6) 0 8 (18.6)
Postinflammatory scar 6 (13.9) 2 (4.7) 4 (9.3)
Posttraumatic scar 2 (4.7) 0 2 (4.7)
Stevens-Johnson syndrome 2 (4.7) 0 2 (4.7)
Table 2: Characteristics of primary KLAL failure.
Cause of KLAL failure Total (N� 17)N (100%)
Chemical
burn (n� 6)
+ermal
burn (n� 1)
Postinflammatory scar
(n� 6)
Posttraumatic scar
(n� 0)
Stevens-Johnson
syndrome (n� 2)
Primary failure 2 (11.8) 1 (16.7) 1 (50.0)
Rejection 2 (11.8) 1 (16.7)
Persistent epithelial
defect 3 (17.6) 1 (16.7) 2 (33.3)
Corneal
neovascularization 7 (41.2) 2 (33.3) 1 (100.0) 2 (33.3) 1 (50.0)
Conjunctivalization 3 (17.6) 1 (16.7) 2 (33.3)
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attributed to a combination of anatomical, physiological,
and immunological properties that prevent the induction
and expression of potentially destructive immune responses
to the transplanted tissue [17].
Simultaneous PK and limbal transplantation carry a high
risk of failure. +e two-step surgical approach, the first for
reconstructing and sustaining ocular surface stability and the
second for improving visual acuity, is preferable and
strongly emphasized in the literature [12–16, 18].
It should be noted that safety and the reduction of
potential postoperative complications also depend on the
time of and the delay in the application of KLAL and optical
PK. In the present study, the range was 9–12 months.
Shimazaki et al. [19] proposed a delay of successive optical
surgical procedures for at least several months after ocular
surface reconstruction. +e application of keratoplasty to
inflamed and vascularized corneas increases the risk of
immunologic rejection and epithelial problems. Solomon
et al. [20] modified their surgical strategy and adopted a two-
step approach by first performing KLAL and, subsequently,
PK at 3–6 months.
+e choice of treatment method, simultaneous or
separated KLAL and PK, also depends on the availability of
donor corneal tissue, as indicated by Han et al. [7].
However, they emphasized that the application of strong
systemic and topical immunosuppression did not pose an
increased risk of rejection in patients who underwent
KLAL concurrently with PK in comparison to those who
received KLAL only. However, Han et al. also recorded the
concurrent rejection of the limbi and central grafted
corneas in four eyes, two of which experienced irreversible
graft failure.
+e abovementioned success of one surgical procedure is
in accordance with the results of Ilari and Daya [21] who
found no difference in KLAL survival with the simultaneous
or subsequent PK. However, KLAL combined with PK
appeared to have a shorter survival time than KLAL followed
by PK.
+e survivability of the first KLAL in the patients in the
present study was 60%. Solomon et al. [20] performed
successive KLAL procedures after the failure of the first
KLAL in 11 of 39 study group patients. Nine eyes required a
second; 1 eye, a third; and 1 eye, a fourth KLAL. +e
prognosis for successful KLAL survival was probably related
to persistent inflammation, severe dry eye, or the asymp-
tomatic and progressive rejection of the KLAL. +us, the
survivability for KLAL, especially repeated applications,
requires more intensive immunosuppression for a pro-
longed, if not indefinite, period [16].
Shi et al. [22] compared simultaneous KLAL and PK to
another surgical technique: total PK for the treatment of
severe corneal burns with total LSCD. +ey reported fewer
complications and a better prognosis for the combined
surgical approach.+ey stressed that the two-stage approach
may act as a physical barrier against the invasion of the
corneal stroma by the vessels and immune cells. In addition,
corneoscleral transplantation is high-risk keratoplasty be-
cause of the oversized graft with a large number of antigens
in the large donor grafts.
Systemic immunosuppression plays a very important
role in the maintenance of clear and functional grafts. +e
rate of immune reactions is the result of the high immu-
nogenic stimulus of the limbal transplant related to the
presence of Langerhans cells and HLA-DR antigens, which
play a crucial role in the afferent arm of the allograft re-
jection [23, 24].
+e results of the application of systemic immunosup-
pressive medication after ocular surface reconstruction in
severe LSCD are concordant with those of Holland and
Schwartz [8]. +e tapering of the two or three systemic
immunosuppressants in concert rather than the discontin-
uation of one concurrent with the continuation of the other
two at high doses is more desirable. It reduces the risk of side
effects from the dangerous medications.
+e increased intraocular pressure and secondary
glaucoma observed in the present study despite the appli-
cation of one PK peripheral iridectomy is more frequent
than the result after procedures involving only the central
part of the cornea. +e current results are comparable to
those obtained by Ti et al. [25], Ang et al. [26], and Jonas
et al. [27] after the application of other tectonic procedures
involving the peripheral cornea.
(a) (b)
Figure 1: (a). Successful keratoplasty after KLAL with double running suture without vascular invasion crossing limbal border of the KLAL
graft. (b) Total failure—superficial and deep vascular ingrowth into corneal bottom after PK with partial melting of both grafts.
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For the best final results of treatment, including the
improvement of visual acuity, elective corneal and lens
surgery, often multistage and repetitive, are necessary. In
this study group, the most frequent procedure was cataract
surgery, alone (20%) or combined with re-PK (7%), as well
as re-PK because of allograft failure or rejection, corneal
scarification, or neovascularization (29%).
+e functional result of the primary treatment of total
LSCD is not the main outcome. Surface reconstruction gives
ability to improve vision offering the patient successful
optical keratoplasty. PK in eyes with inactive primary disease
and without inflammation leads to better and more pre-
dictive results.
In conclusion, because of the complex nature of the total
LSCD, successful KLAL still carries a high risk of subsequent
PK failure. Visual function remains the second aim of
treatment. Further investigations and the development of
new surgical techniques and appropriate immunosuppres-
sive approaches are still necessary for improving the final
results of treatment.
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